Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid

Objective: to evaluate the effect of the generic drug of zoledronic acid on bone mineral density (BMD) and markers of bone metabolism in patients with osteoporosis (OP), as well as possible long-term adverse reactions (AR) 12 months after drug administration.Patients and methods. The study included...

Celý popis

Podrobná bibliografie

Hlavní autoři:	N. V. Toroptsova, A. O. Efremova, T. A. Korotkova, O. V. Dobrovolskaya, N. V. Demin, A. Yu. Feklistov, E. Yu. Samarkina, M. V. Cherkasova
Médium:	Artigo
Jazyk:	Russo
Vydáno:	IMA-PRESS LLC 2022-05-01
Edice:	Современная ревматология
Témata:	osteoporosis zoledronic acid bone mineral density fractures bone metabolism
On-line přístup:	https://mrj.ima-press.net/mrj/article/view/1275
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!